A Study of the Safety and Activity of Eculizumab in Pediatric Participants With Relapsing Neuromyelitis Optica Spectrum Disorder

Study Sponsor: Alexion Pharmaceuticals

Clinical Trials.Gov Identifier: NCT04155424